Brought to you by WBIW News and Network Indiana
Last updated on Thursday, May 3, 2007
(WEST LAFAYETTE) - The Purdue Research Foundation is licensing new technology to a San Diego company that could be mass-produced into a bird flu vaccine.
The vaccine technology transports an extra gene related to the influenza virus. The extra gene produces a protein in the host's cells and triggers an immune response against bird flu.
The process still needs approval from the food and drug administration.
1340 AM WBIW welcomes comments and suggestions by calling 812.277.1340 during normal business hours or by email at comments@wbiw.com
© Ad-Venture Media, Inc. All Rights Reserved.